Gastrointestinal Cancer,Pancreatic Cancer NCI-MATCH Phase II: Tolerable TRAEs from Vismdegib Oral Intake Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer Phase 2 eNRGy Study: Zenocutuzumab for NRG1+ Cancers Assessment Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer Phase 2 Study: Rucaparib-resistant BRCA/PALB2 Pancreatic Cancer Treatment Mar 27, 2023
Gastrointestinal Cancer Cabozantinib Plus Durvalumab in Advanced GI Cancers: CAMILLA Trial Results Mar 23, 2023
Gastrointestinal Cancer EMT-Related Genes Not Prognostic in Metastatic Colorectal Cancer: FIRE-3 Trial Mar 14, 2023
Gastrointestinal Cancer Pooled Safety Analysis of Trifluridine/Tipiracil in Metastatic Cancer - Phase III Mar 14, 2023
Gastrointestinal Cancer STELLAR-303 Study: XL092 and Atezolizumab vs. Regorafenib in mCRC Mar 14, 2023
Gastrointestinal Cancer Tislelizumab Outperforms Chemotherapy in 1L Advanced GC/GEJC: Phase 3 Study Mar 14, 2023